Skip to main content
Mereo BioPharma Group plc logo

Mereo BioPharma Group plc — Investor Relations & Filings

Ticker · MREO ISIN · GB00BZ4G2K23 LEI · 213800U8JQHIJOS5AS09 US Manufacturing
Filings indexed 635 across all filing types
Latest filing 2020-06-08 Major Shareholding Noti…
Country GB United Kingdom
Listing US MREO

About Mereo BioPharma Group plc

https://www.mereobiopharma.com/

Mereo BioPharma Group plc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for rare diseases with limited or no treatment options. The company's strategy involves acquiring and advancing promising clinical-stage product candidates that have been de-prioritized by larger pharmaceutical or biotechnology companies. This capital-efficient model allows it to develop a specialized pipeline. Its two lead programs are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for Alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). Mereo BioPharma also engages in strategic partnerships and out-licenses other clinical assets to deliver impactful treatments to patients.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. It explicitly details a change in share ownership by Invesco Ltd. in Mereo BioPharma Group plc, crossing a reporting threshold. This is a standard regulatory disclosure for major shareholding notifications, which corresponds to the 'Major Shareholding Notification' category.
2020-06-08 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is the regulatory standard in the UK for disclosing significant changes in share ownership (major shareholding notifications). The text explicitly identifies the issuer (Mereo BioPharma Group plc) and the person subject to the notification (Baker Bros. Advisors LP), detailing the percentage of voting rights held. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2020-06-08 English
SC 13G/A
Major Shareholding Notification
2020-06-05 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is a regulatory requirement for shareholders to disclose when their voting rights in a company cross certain thresholds. This is a classic 'Major Shareholding Notification' filing, which corresponds to the code 'MRQ'.
2020-06-05 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to disclose when their voting rights in a company cross certain thresholds. This specific document type is categorized as a 'Major Shareholding Notification' (MRQ) in the provided filing definitions.
2020-06-05 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Mereo BioPharma Group PLC, with the SEC. It includes an exhibit index listing agreements related to securities purchase, registration rights, convertible loan notes, warrants, and a press release. The document is short (1934 characters) and primarily serves as a report of recent material events or agreements, typical of Form 6-K filings. It does not contain full financial statements or detailed financial analysis. Form 6-K filings are periodic reports for foreign private issuers to disclose material information and are generally classified under Regulatory Filings (RNS) as they do not fit into other specific report categories like Annual Report or Interim Report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-06-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.